Clinical trials
Recruiting Phase 4 Major Depressive Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nova Scotia Health Authority | 2 |
| Stony Brook University | 2 |
| Axsome Therapeutics, Inc. | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Massachusetts General Hospital | 1 |
| Medical University of Vienna | 1 |
| NYU Langone Health | 1 |
| Neurocrine Biosciences | 1 |
| Nordsjaellands Hospital | 1 |
| Region Örebro County | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Major Depressive Disorder | 16 |
| Bipolar Disorder | 3 |
| Alzheimer Disease | 1 |
| Psychotic Disorders | 1 |
| Recurrence | 1 |
| Schizophrenia | 1 |
| Sleep Initiation and Maintenance Disorders | 1 |
| Tardive Dyskinesia | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.